Form 8-K - Current report:
SEC Accession No. 0001062822-25-000033
Filing Date
2025-06-03
Accepted
2025-06-03 16:04:41
Documents
21
Period of Report
2025-06-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lxrx-20250602.htm   iXBRL 8-K 45776
2 EX-10.1 exh1012017equityincentiv.htm EX-10.1 51217
3 EX-10.2 exh1022017non-employeedi.htm EX-10.2 36200
7 exh1012017equityincentiv001.jpg GRAPHIC 850297
8 exh1012017equityincentiv002.jpg GRAPHIC 1008116
9 exh1012017equityincentiv003.jpg GRAPHIC 984891
10 exh1012017equityincentiv004.jpg GRAPHIC 243706
11 exh1022017non-employeedi001.jpg GRAPHIC 934939
12 exh1022017non-employeedi002.jpg GRAPHIC 1088019
13 exh1022017non-employeedi003.jpg GRAPHIC 126491
  Complete submission text file 0001062822-25-000033.txt   7497063

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lxrx-20250602.xsd EX-101.SCH 1788
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lxrx-20250602_lab.xml EX-101.LAB 22532
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lxrx-20250602_pre.xml EX-101.PRE 13047
23 EXTRACTED XBRL INSTANCE DOCUMENT lxrx-20250602_htm.xml XML 2872
Mailing Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381
Business Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Filer) CIK: 0001062822 (see all company filings)

EIN.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30111 | Film No.: 251019305
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)